Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan CEO to stay on past scheduled exit at board request pending release of critical drug data
Elan CEO to stay on past scheduled exit at board request pending release of critical drug data
Elan CEO to stay on past scheduled exit at board request pending release of critical drug data
Submitted by
admin
on March 1, 2012 - 12:30pm
Source:
Yahoo/AP
News Tags:
Elan
Pharma CEOs
Kelly Martin
Alzheimer's disease
Headline:
Elan CEO to stay on past scheduled exit at board request pending release of critical drug data
Do Not Allow Advertisers to Use My Personal information
